Point Therapeutics: Clinical Trials

7 trials sponsored by Point Therapeutics, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 3 terminated. 5 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Completed 4, Terminated 1
Phase 32Terminated 2

Follow Point Therapeutics: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy
talabostat, pemetrexed - Carcinoma, Non-Small-Cell Lung, Lung Cancer
Phase 3TerminatedPoint Therapeutics4002006-02-012007-06-08
Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy
talabostat mesylate, docetaxel - Carcinoma, Non-Small Cell Lung
Phase 3TerminatedPoint Therapeutics4002006-01-012007-06-08
Study of Talabostat and Cisplatin in Advanced Melanoma
talabostat (PT-100) tablets, cisplatin - Melanoma, Skin Cancer
Phase 2CompletedPoint Therapeutics2007-06-08
Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL)
Talabostat mesylate (PT-100) tablets, Rituximab - Chronic Lymphocytic Leukemia
Phase 2CompletedPoint Therapeutics2015-03-25
Study of Talabostat and Docetaxel in Advanced Non-Small Cell Lung Cancer
talabostat (PT-100) tablets, Docetaxel - Lung Cancer
Phase 2CompletedPoint Therapeutics2007-06-08
Study of Talabostat in Advanced Melanoma
talabostat (PT-100) tablets - Melanoma, Skin Cancer
Phase 2CompletedPoint Therapeutics2007-06-08
Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas
talabostat mesylate tablets, gemcitabine - Pancreatic Cancer, Neoplasm Metastasis
Phase 2TerminatedPoint Therapeutics602007-06-08

Conditions studied

Lung Neoplasms (3)  ·  Carcinoma, Non-Small-Cell Lung (2)  ·  Melanoma (2)  ·  Skin Neoplasms (2)  ·  Adenocarcinoma (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Neoplasm Metastasis (1)  ·  Pancreatic Neoplasms (1)

Interventions

talabostat (5)  ·  Tablets (4)  ·  PT-100 dipeptide (3)  ·  Docetaxel (2)  ·  Cisplatin (1)  ·  Gemcitabine (1)  ·  Pemetrexed (1)  ·  Rituximab (1)

Countries

United States (7)